Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Feb 15, 2007

Amsterdam Molecular Therapeutics and University of Barcelona to Study Gene Regulation

  • Amsterdam Molecular Therapeutics and the University of Barcelona will work together to develop a gene therapy capable of regulating mitochondrial fatty acid metabolism and insulin-resistance. They research will cover the areas of gene regulation of fatty acid oxidation, and obesity.

    The partnership will initially aim to demonstrate the safety and efficacy in various preclinical models. If successful the product will be taken into clinical development and commercialization.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »